🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Category

General business news

8435 posts
Business News Today infographic showing NanoXplore’s graphene commercialisation progress, including C$117.3 million of fiscal 2026 revenue, C$1.9 million of adjusted EBITDA, C$11.8 million annual loss and fiscal 2027 revenue guidance of C$130 million to C$140 million.
Read More

NanoXplore is targeting positive cash flow. Is graphene finally moving from laboratory promise to industrial scale?

Graphene has spent years surrounded by extraordinary scientific expectations, but large-scale commercial adoption depends on mundane issues such as repeatable quality, customer qualification, production cost and cash generation. NanoXplore’s latest strategy provides a useful test of whether the material is entering that more mature phase.